logo
OS Therapies' OST-HER2 Immunotherapy for Osteosarcoma Featured in Upcoming Movie Shelter Me: The Cancer Pioneers

OS Therapies' OST-HER2 Immunotherapy for Osteosarcoma Featured in Upcoming Movie Shelter Me: The Cancer Pioneers

OS Therapies (NYSE-A: OSTX) ('OS Therapies' or 'the Company'), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in the upcoming movie Shelter Me: The Cancer Pioneers. The movie offers a look into canine comparative oncology, a field that compares treatment of cancers in dogs to those in people, and covers developing treatments for rare forms of cancer. OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2. The movie will premiere on April 3, 2025 at AMC Century City in Los Angeles and will be available to stream through the PBS app and on PBS.org starting in May.
'Our team is dedicated to advancing a treatment for osteosarcoma and are proud to see our immunotherapy in Shelter Me: The Cancer Pioneers,' stated OS Therapies' CEO Paul Romness. 'Comparative oncology is an important area of research for us because of the striking genetic homology of over 96% between human and canine osteosarcoma.' OST-HER2 is an investigational drug and is not currently approved to treat osteosarcoma or any other disease.
Shelter Me: The Cancer Pioneers also features leading scientists at the National Cancer Institute / National Institutes of Health, the University of Pennsylvania, the University of Illinois, the University of Wisconsin, and Colorado State University. It is part of an Emmy Award-winning PBS series, Shelter Me, that celebrates the life-changing relationships between people and animals.
A trailer of the movie can be viewed here.
About OS Therapies
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OST-HER2, the Company's lead asset, is an immunotherapy leveraging the immune-stimulatory effects of Listeria bacteria to initiate a strong immune response targeting the HER2 protein. OST-HER2 has received Rare Pediatric Disease Designation (RPDD) from the US Food & Drug Administration and Fast-Track and Orphan Drug designations from the US FDA and European Medicines Agency. The Company positive data in its Phase 2b clinical trial of OST-HER2 in recurrent, fully resected, lung metastatic osteosarcoma demonstrating statistically significant benefit in the 12-month event free survival (EFS) primary endpoint of the study. The Company anticipates submitting a Biologics Licensing Application (BLA) to the US FDA for OST-HER2 in osteosarcoma in 2025 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma.
In addition, OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) and Drug Conjugates (DC), known as tunable ADC (tADC), which features tunable, tailored antibody-linker-payload candidates. This platform leverages the Company's proprietary silicone Si-Linker and Conditionally Active Payload (CAP) technology, enabling the delivery of multiple payloads per linker. For more information, please visit www.ostherapies.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements within the meaning of the federal securities laws. These forward-looking statements and terms such as 'anticipate,' 'expect,' 'intend,' 'may,' 'will,' 'should' or other comparable terms involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of OS Therapies and members of its management, as well as the assumptions on which such statements are based. OS Therapies cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to the approval of OST-HER2 by the US FDA and grant of a priority review voucher and other risks and uncertainties described in 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in the Company's registration statement on Form S-1 filed with the Securities and Exchange Commission (the 'SEC') on November 12, 2024, as amended on November 27, 2024, and other subsequent documents we file with the SEC, including but not limited to our Quarterly Reports on Form 10-Q. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by the federal securities laws, OS Therapies specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Jack Doll
571.243.9455
[email protected]://x.com/OSTherapies
https://www.instagram.com/ostherapies/
https://www.facebook.com/OSTherapies/
https://www.linkedin.com/company/os-therapies/
SOURCE: OS Therapies
Copyright Business Wire 2025.
PUB: 03/25/2025 07:40 AM/DISC: 03/25/2025 07:39 AM
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PSEG recommends shareholders reject "mini-tender" offer by TRC Capital Investment Corporation
PSEG recommends shareholders reject "mini-tender" offer by TRC Capital Investment Corporation

Yahoo

time19 minutes ago

  • Yahoo

PSEG recommends shareholders reject "mini-tender" offer by TRC Capital Investment Corporation

NEWARK, N.J., Aug. 1, 2025 /PRNewswire/ -- Public Service Enterprise Group (NYSE: PEG) today announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada, to purchase up to 1.5 million shares of PSEG common stock at a price of $80.60 per share. TRC Capital Investment's offer price of $80.60 per share is approximately 4.51% lower than the $84.41 closing share price of PSEG's common stock on July 21, 2025, the last trading day prior to the date of the offer, and approximately 9.4% lower than the $88.97 closing share price on August 1, 2025. The offer is for approximately 0.3% of the shares of PSEG common stock outstanding as of the offer date. PSEG is not associated in any way with TRC Capital Investment or its unsolicited mini-tender offer. PSEG recommends that shareholders do not tender their shares in response to TRC Capital Investment's offer because the offer is at a price below the market price for PSEG's shares as of the date of the offer and as of August 1, 2025, and subject to numerous conditions. Shareholders who have already tendered their shares may withdraw them at any time prior to the expiration of the offer, in accordance with the terms of TRC Capital Investment's offer. The offer is currently scheduled to expire at 12:00 a.m. Eastern Time on August 20, 2025. TRC Capital Investment may extend the offering period at its discretion. TRC Capital Investment has made many similar mini-tender offers for shares of other companies. Mini-tender offers seek to acquire less than 5 percent of a company's shares outstanding, thereby avoiding many disclosure and procedural requirements of the U.S. Securities and Exchange Commission (SEC) that would otherwise apply. As a result, mini-tender offers do not provide investors with the same level of protections as provided for larger tender offers under U.S. securities laws. The SEC has cautioned investors that some bidders making mini-tender offers at below-market prices are "hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price." More on the SEC's guidance to investors on mini-tender offers is available at [ PSEG urges investors to obtain current market quotations for their shares, to consult with their broker or financial advisor, and to exercise caution with respect to TRC Capital Investment's offer. PSEG encourages brokers and dealers, as well as other market participants, to review the SEC's letter regarding broker-dealer mini-tender offer dissemination and disclosure at [ About PSEGPublic Service Enterprise Group (PSEG) (NYSE: PEG) is a predominantly regulated infrastructure company operating New Jersey's largest transmission and distribution utility, serving approximately 2.4 million electric and 1.9 million natural gas customers. PSEG also owns an independent fleet of 3,758 MW of carbon-free, baseload nuclear power generating units in NJ and PA. Guided by its Powering Progress vision, PSEG aims to power a future where people use less energy, and it's cleaner, safer and delivered more reliably than ever. PSEG is a member of the S&P 500 Index and has been named to the Dow Jones Sustainability North America Index for 17 consecutive years. PSEG's businesses include Public Service Electric and Gas Co. (PSE&G), PSEG Power and PSEG Long Island ( From time to time, PSEG and PSE&G release important information via postings on their corporate Investor Relations website at Investors and other interested parties are encouraged to visit the Investor Relations website to review new postings. You can sign up for automatic email alerts regarding new postings at the bottom of the webpage at or by navigating to the Email Alerts webpage here. CONTACTS: Investor Relations Media Relations PSEG-IR-GeneralInquiry@ (973) View original content to download multimedia: SOURCE PSEG Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Bloom Energy Plunged Today Before Recovering
Why Bloom Energy Plunged Today Before Recovering

Yahoo

timean hour ago

  • Yahoo

Why Bloom Energy Plunged Today Before Recovering

Key Points Bloom's energy server technology is a great fit for AI data centers. Last night's earnings report was strong, with Bloom beating revenue expectations. However, the stock had already rallied on a big announcement with Oracle last week, leading to profit taking following earnings. 10 stocks we like better than Bloom Energy › Shares of on-premises electricity generator provider Bloom Energy (NYSE: BE) plunged initially today, down 13% at one point, before recovering to a 1.4% decline as of 3:26 p.m. ET. Bloom reported second-quarter earnings last night, beating revenue estimates but missing the mark on the adjusted (non-GAAP) earnings-per-share (EPS) line. Of course, Bloom is a growth stock, so the top line matters more. However, since the stock had already had a massive run following recent deals with big data center and utility names, investors appeared to take profits on the less-than-absolutely perfect quarter. Management also merely "reaffirmed" 2025 guidance, without raising numbers. Bloom Energy is blooming at AI data centers In Q2, revenue climbed 19.5% to $401.2 million, beating expectations, while adjusted losses per share narrowed from $0.27 to $0.18, missing expectations of $0.08. Bloom management also said it was looking forward to doubling its production capacity, which will no doubt entail higher costs. But that capacity growth appears to be backed up by strong demand. Bloom's energy server product can produce electricity from either natural gas or hydrogen via a chemical process without combustion, thereby lowering emissions. The technology appears to be on the brink of much wider adoption, given the need for reliable, cleaner electricity at AI data centers. Last week, Bloom announced a direct partnership with Oracle (NYSE: ORCL) in which Bloom will supply on-site power to Oracle data centers within 90 days. The announcement sent the stock flying, and CEO KR Sridhar noted the partnership may pave the way for more direct deals with AI hyperscalers. On the conference call with analysts, Sridhar noted the Oracle deal is "the first time we as a company are directly interacting with the hyperscaler as our are the primary source, and it is load following. So it will prove that we can load follow at large scale." Earnings seem to be a "sell-the-news" event Bloom has exciting AI-fueled growth potential, but since the stock had already rocketed higher last week on the Oracle announcement, it appears investors were eager to take profits on the less-than-perfect quarter. However, the bounce back following today's initial plunge indicates there weren't really any red flags to speak of. Valuation would be the biggest risk here, as Bloom's stock is quite expensive. Shares trade for 5.5 times sales and 80 times this year's adjusted earnings estimates. Should you buy stock in Bloom Energy right now? Before you buy stock in Bloom Energy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Bloom Energy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Billy Duberstein and/or his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Oracle. The Motley Fool has a disclosure policy. Why Bloom Energy Plunged Today Before Recovering was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Avidia Bancorp, Inc. Reports Second Quarter 2025 Financial Results
Avidia Bancorp, Inc. Reports Second Quarter 2025 Financial Results

Business Wire

timean hour ago

  • Business Wire

Avidia Bancorp, Inc. Reports Second Quarter 2025 Financial Results

HUDSON, Mass.--(BUSINESS WIRE)--Avidia Bancorp, Inc. (the 'Company') (NYSE: 'AVBC'), the holding company of Avidia Bank, today reported second quarter financial results of Assabet Valley Bancorp, the former mutual holding company of Avidia Bank. As previously reported, Assabet Valley Bancorp completed its mutual-to-stock conversion transaction effective July 31, 2025, which resulted in the Company completing its initial public offering of shares of its common stock and becoming the stock holding company of Avidia Bank. Selected Financial Highlights for the Second Quarter of 2025 Statement of Operations: Quarterly net income was $3.9 million, compared to a net loss of $11.6 million for the first quarter. Quarterly net interest income increased by $1.4 million from the first quarter to $20.6 million. Net interest margin increased by 15 basis points from the first quarter to 3.19%. The cost of interest-bearing liabilities decreased by 13 basis points. The cost of total deposits fell 14 basis points to 1.36%. Provision for credit losses totaled $1.1 million. Quarterly non-interest income increased by $1.5 million from the first quarter to $5.2 million. Quarterly non-interest expense decreased by $2.1 million from the first quarter to $19.8 million. Salaries and employee benefits decreased $2.7 million from the first quarter as there were incentive plan terminations and increased short-term incentive payouts in the previous quarter. The efficiency ratio was 76.4%, compared to 95.2% in the first quarter. Income tax expense was $1.2 million. Balance Sheet: Total cash and cash equivalents increased by $225 million from the first quarter, primarily related to the funds received from the IPO subscription offering. Gross loans increased by $15.0 million from the first quarter to $2.25 billion. Deposits increased by $309 million from the first quarter to $2.44 billion, also primarily related to funds received from the IPO subscription offering. Federal Home Loan Bank advances decreased by $65 million from the first quarter to $260.0 million. Total capital increased by $5.4 million from the first quarter to $191.4 million. Asset Quality: Non-accrual loans to total loans was 0.50% compared to 0.53% in the first quarter. About Avidia Bancorp, Inc. Avidia Bancorp, Inc. is the bank holding company of Avidia Bank. Avidia Bank is a Massachusetts-chartered stock savings bank. With headquarters in Hudson, Massachusetts, it also operates nine full-service banking offices in western Middlesex County and eastern Worcester County, in Massachusetts. Forward-Looking Statements Statements contained in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by use of the words "believe," "expect," "anticipate," "intend," "estimate," "assume," "outlook," "will," "should," and other similar expressions which do not relate to historical matters. Although we believe that these forward-looking statements are based on reasonable estimates and assumptions, they are not guarantees of future performance. You should not place undue reliance on forward-looking statements because they are subject to significant risks, uncertainties and other factors which are, in some cases, beyond our control. Our actual results could differ materially from those presented in the forward-looking statements as a result of, among other factors, changes in general business and economic conditions nationwide and in our local markets, including changes which adversely affect borrowers' ability to service and repay loans; changes in customer behavior due to political, business and economic conditions, including inflation; conditions in the capital and debt markets; reductions in net interest income resulting from interest rate volatility and changes in the balances and mix of our loans and deposits; changes in market interest rates and real estate values; decreases in the value of securities and other assets or in deposit levels necessitating increased borrowing to fund loans and investments; competition from other financial institutions; changes in legislation or regulation and accounting principles, policies and guidelines; cybersecurity incidents; fraud; natural disasters; the risk that we may be unsuccessful in implementing our business strategy; and the other risks and uncertainties disclosed in Avidia Bancorp, Inc.'s definitive prospectus dated May 13, 2025, as filed the U.S. Securities and Exchange Commission. Forward looking statements speak only as of the date of this release, and we do not undertake any obligation to update or revise any of them to reflect events or circumstances occurring after the date of this release or to reflect the occurrence of unanticipated events, except as may be required by applicable law or regulation. Assabet Valley Bancorp Consolidated Balance Sheets (Unaudited) As of June 30, 2025 Change From (In thousands) June 30, 2025 March 31, 2025 June 30, 2024 March 31, 2025 June 30, 2024 Assets Cash and due from banks $ 24,667 $ 24,282 $ 15,394 $ 385 1.6 % $ 9,273 60.2 % Short-term investments 283,919 58,800 58,671 225,119 382.9 225,248 383.9 Total cash and cash equivalents 308,586 83,082 74,065 225,504 271.4 234,521 316.6 Securities available for sale, at fair value 266,249 261,946 274,900 4,303 1.6 (8,651 ) (3.1 ) Equity securities, at fair value - - 13,430 - - (13,430 ) (100.0 ) Securities held to maturity, at amortized cost 16,747 16,746 16,746 1 - 1 - Total securities 282,996 278,692 305,076 4,304 - (22,080 ) - Federal Home Loan Bank stock, at cost 12,083 14,729 16,210 (2,646 ) (18.0 ) (4,127 ) (25.5 ) Loans held for sale - 711 1,485 (711 ) (100.0 ) (1,485 ) (100.0 ) Total loans 2,248,021 2,233,033 2,145,471 14,988 0.7 102,550 4.8 Less: Allowance for credit losses (23,425 ) (21,849 ) (20,875 ) (1,576 ) 7.2 (2,550 ) 12.2 Net loans 2,224,596 2,211,184 2,124,596 13,412 0.6 100,000 4.7 Premises and equipment, net 29,098 29,020 28,133 78 0.3 965 3.4 Bank-owned life insurance 36,093 35,805 35,004 288 0.8 1,089 3.1 Accrued interest receivable 8,922 8,802 9,110 120 1.4 (188 ) (2.1 ) Net deferred tax asset 11,323 11,738 14,520 (415 ) (3.5 ) (3,197 ) (22.0 ) Goodwill 11,936 11,936 11,936 - - - - Mortgage servicing rights 3,253 3,289 3,483 (36 ) (1.1 ) (230 ) (6.6 ) Other assets 29,022 17,643 28,700 11,379 64.5 322 1.1 Total Assets $ 2,957,908 $ 2,706,631 $ 2,652,318 $ 251,277 9.3 % $ 305,590 11.5 % Liabilities Deposits $ 2,439,608 $ 2,131,068 $ 2,021,839 $ 308,540 14.5 % $ 417,769 20.7 % Federal Home Loan Bank advances 260,000 325,000 372,300 (65,000 ) (20.0 ) (112,300 ) (30.2 ) Subordinated debt 27,738 27,715 27,605 23 0.1 133 0.5 Mortgagors' escrow accounts 3,498 3,763 3,042 (265 ) (7.0 ) 456 15.0 Accrued expenses and other liabilities 35,638 33,028 40,487 2,610 7.9 (4,849 ) (12.0 ) Total liabilities $ 2,766,482 $ 2,520,574 $ 2,465,273 $ 245,908 9.8 % $ 301,209 12.2 % Capital: Retained earnings $ 207,555 $ 203,683 $ 209,682 $ 3,872 1.9 % $ (2,127 ) (1.0 ) % Accumulated other comprehensive loss (16,129 ) (17,626 ) (22,637 ) 1,497 (8.5 ) 6,508 (28.7 ) Total capital $ 191,426 $ 186,057 $ 187,045 $ 5,369 2.9 $ 4,381 2.3 % Total Liabilities and Capital $ 2,957,908 $ $ 2,652,318 $ 251,277 9.3 % $ 305,590 11.5 % Expand Assabet Valley Bancorp Consolidated Statements of Operations QTD (Unaudited) Three Months Ended June 30, 2025 Change Three Months Ended From Three Months Ended (In thousands) June 30, 2025 March 31, 2025 June 30, 2024 March 31, 2025 June 30, 2024 Interest and dividend income: Loans, including fees $ 28,883 $ 28,183 $ 27,492 $ 700 2.5 % $ 1,391 5.1 % Securities 2,555 2,651 2,833 (96 ) (3.6 ) (278 ) (9.8 ) Other 421 215 568 206 95.8 (147 ) (25.9 ) Total interest and dividend income 31,859 31,049 30,893 810 2.6 966 3.1 Interest expense: Deposits 7,242 7,731 8,285 (489 ) (6.3 ) (1,043 ) (12.6 ) Federal Home Loan Bank advances 3,647 3,792 3,985 (145 ) (3.8 ) (338 ) (8.5 ) Subordinated debt 352 315 315 37 11.7 37 11.7 Total interest expense 11,241 11,838 12,585 (597 ) (5.0 ) (1,344 ) (10.7 ) Net interest income: 20,618 19,211 18,308 1,407 7.3 2,310 12.6 Provision expense (reversal) for credit losses 1,071 17,616 (320 ) (16,545 ) (93.9 ) 1,391 (434.7 ) Net interest income, after provision expense (reversal) for credit losses 19,547 1,595 18,628 17,952 1125.5 919 4.9 Non-interest income: Customer service fees 884 901 762 (17 ) (1.9 ) 122 16.0 Net (loss) on sale of securities available for sale (78 ) (541 ) (1,366 ) 463 (85.6 ) 1,288 (94.3 ) Net recognized gain on equity securities - - 273 - - (273 ) (100.0 ) Net write down on premises and equipment no longer in use - (356 ) - 356 (100.0 ) - - Payment processing income 2,079 2,192 1,798 (113 ) (5.2 ) 281 15.6 Income on bank-owned life insurance 289 279 195 10 3.6 94 48.2 Mortgage banking income 162 16 408 146 912.5 (246 ) (60.3 ) Investment commissions 312 350 352 (38 ) (10.9 ) (40 ) (11.4 ) Debit card income 793 525 573 268 51.0 220 38.4 Credit card income 58 49 335 9 18.4 (277 ) (82.7 ) Other 747 312 115 435 139.4 632 549.6 Total non-interest income 5,246 3,727 3,445 1,519 40.8 1,801 52.3 Non-interest expense: Salaries and employee benefits 8,909 11,566 8,701 (2,657 ) (23.0 ) 208 2.4 Occupancy and equipment 2,042 2,018 2,384 24 1.2 (342 ) (14.3 ) Data processing 2,994 3,378 2,218 (384 ) (11.4 ) 776 35.0 Professional fees 1,088 661 739 427 64.6 349 47.2 Payment processing 932 1,043 992 (111 ) (10.6 ) (60 ) (6.0 ) Deposit insurance 780 632 687 148 23.4 93 13.5 Advertising 310 265 334 45 17.0 (24 ) (7.2 ) Telecommunications 96 92 101 4 4.3 (5 ) (5.0 ) Problem loan and foreclosed real estate, net 194 112 100 82 73.2 94 94.0 Other general and administrative 2,418 2,064 2,707 354 17.2 (289 ) (10.7 ) Total non-interest expense 19,763 21,831 18,963 (2,068 ) (9.5 ) 800 4.2 Income (loss) before income tax expense 5,030 (16,509 ) 3,110 21,539 (130.5 ) 1,920 61.7 Income tax expense (benefit) 1,158 (4,922 ) 759 6,080 (123.5 ) 399 52.6 Net income (loss) $ 3,872 $ (11,587 ) $ 2,351 $ 15,459 (133.4 ) % $ 1,521 64.7 % Expand Assabet Valley Bancorp Consolidated Statements of Operations YTD (Unaudited) Six Months Ended Six Months Ended June 30, 2025 Change (In thousands) June 30, 2025 June 30, 2024 From Six Months Ended June 30, 2024 Interest and dividend income: Loans, including fees $ 57,067 $ 54,750 $ 2,317 4.2 % Securities 5,206 4,953 253 5.1 Other 636 1,038 (402 ) (38.7 ) Total interest and dividend income 62,909 60,741 2,168 3.6 Interest expense: Deposits 14,973 15,872 (899 ) (5.7 ) Federal Home Loan Bank advances 7,439 8,344 (905 ) (10.8 ) Subordinated debt 667 630 37 5.9 Total interest expense 23,079 24,846 (1,767 ) (7.1 ) Net interest income: 39,830 35,895 3,935 11.0 Provision expense (reversal) for credit losses 18,687 310 18,377 5,928.1 Net interest income, after provision expense for credit losses 21,143 35,585 (14,442 ) (40.6 ) Non-interest income: Customer service fees 1,785 1,620 165 10.2 Net (loss) on sale of securities available for sale (619 ) (1,366 ) 747 (54.7 ) Net recognized gain on equity securities - 1,637 (1,637 ) (100.0 ) Net write down on premises and equipment no longer in use (356 ) - (356 ) (100.0 ) Payment processing income 4,271 3,660 611 16.7 Income on bank-owned life insurance 568 407 161 39.6 Mortgage banking income 178 858 (680 ) (79.3 ) Investment commissions 662 660 2 - Debit card income 1,318 1,109 209 18.8 Credit card income 107 566 (459 ) (81.1 ) Other 1,060 193 867 449.2 Total non-interest income 8,974 9,344 (370 ) (4.0 ) Non-interest expense: Salaries and employee benefits 20,475 17,308 3,167 18.3 Occupancy and equipment 4,060 4,468 (408 ) (9.1 ) Data processing 6,372 4,423 1,949 44.1 Professional fees 1,749 1,254 495 39.5 Payment processing 1,975 2,012 (37 ) (1.8 ) Deposit insurance 1,412 1,396 16 1.1 Advertising 575 779 (204 ) (26.2 ) Telecommunications 188 205 (17 ) (8.3 ) Problem loan and foreclosed real estate, net 306 184 122 66.3 Other general and administrative 4,484 5,031 (547 ) (10.9 ) Total non-interest expense 41,596 37,060 4,536 12.2 Income (loss) before income tax expense (11,479 ) 7,869 (19,348 ) (245.9 ) Income tax expense (benefit) (3,764 ) 1,973 (5,737 ) (290.8 ) Net income (loss) $ (7,715 ) $ 5,896 $ (13,611 ) (230.9 ) % Expand Assabet Valley Bancorp Average Balances and Average Yields And Costs (Unaudited) For the Quarters Ended June 30, 2025 March 31, 2025 June 30, 2024 (Dollars in thousands) Average Outstanding Balance Interest Average Yield/ Rate Average Outstanding Balance Interest Average Yield/Rate Average Outstanding Balance Interest Average Yield/ Rate Interest-earning assets: Short-term investments $ 67,357 $ 421 2.51 % $ 37,105 $ 215 2.35 % $ 49,032 $ 568 4.66 % Securities 296,321 2,555 3.46 309,608 2,651 3.47 352,204 2,833 3.24 Loans 2,229,893 28,883 5.20 2,214,952 28,183 5.16 2,015,649 27,492 5.49 Total interest-earning assets 2,593,571 31,859 4.93 2,561,665 31,049 4.92 2,416,885 30,893 5.14 Noninterest-earning assets 122,176 105,220 104,623 Total assets $ 2,715,747 $ 2,666,885 $ 2,521,508 Interest-bearing liabilities: NOW accounts $ 697,452 $ 700 0.40 % $ 690,014 $ 813 0.48 % $ 605,633 $ 737 0.49 % Money market accounts 270,969 848 1.26 260,430 842 1.31 299,203 1,117 1.50 Regular and other savings accounts 401,215 2,278 2.28 383,017 2,098 2.22 348,440 2,231 2.58 Certificates of deposit 347,419 3,416 3.94 387,556 3,978 4.16 246,367 4,200 6.86 Total interest-bearing deposits 1,717,055 7,242 1.69 1,721,017 7,731 1.82 1,499,643 8,285 2.22 FHLB advances and other borrowings (1) 333,834 3,647 4.38 339,814 3,792 4.53 362,083 3,985 4.43 Subordinated debt 27,782 352 5.08 27,691 315 4.61 27,592 315 4.59 Total interest-bearing liabilities 2,078,671 11,241 2.17 2,088,522 11,838 2.30 1,889,319 12,585 2.68 Noninterest-bearing demand deposits 415,035 336,000 388,359 Other noninterest-bearing liabilities 33,242 45,439 43,526 Total liabilities 2,526,948 2,469,961 2,321,203 Total capital 188,799 196,924 200,305 Total liabilities and capital $ 2,715,747 $ 2,666,885 $ 2,521,508 Net interest income $ 20,618 $ 19,211 $ 18,308 Net interest rate spread (2) 2.76 % 2.62 % 2.46 % Net interest-earning assets (3) $ 514,900 $ 473,143 $ 527,566 Net interest margin (4) 3.19 % 3.04 % 3.05 % Average interest-earning assets to interest-bearing liabilities 124.77 % 122.65 % 127.92 % (1) Average balances for borrowings includes the financing lease obligation which is presented under other liabilities on the consolidated balance sheet. (2) Net interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate of interest-bearing liabilities. (3) Net interest-earning assets represent total interest-earning assets less total interest-bearing liabilities. (4) Net interest margin represents net interest income divided by average total interest-earning assets. Expand

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store